ENTX vs NWSA · $58.2M cap vs rev $9.03B
Entera Bio Ltd (ENTX) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
Entera Bio Ltd (ENTX) is a biotechnology company listed on US.
NWSA (NWSA) common stock.
Latest reported ENTX revenue for 2026-06-30 was $0. Net income was -$10.8M. ENTX currently screens at market cap $58.2M.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
ENTX currently screens at market cap $58.2M. NWSA currently screens at market cap $0.
Not investment advice. Open the ENTX and NWSA stock pages for the full models.
Not investment advice.